Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer

International Journal of Gynecological Cancer

Volumn 16, Issue 2, 2006, Pages 708-717

  Lu, X ^a,c   Feki, A ^b  

^a FUDAN UNIVERSITY   (China)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Cervical cancer; HPV; p53

Indexed keywords

PROTEIN E6; PROTEIN P53; VIRUS DNA;

ARTICLE; CANCER GROWTH; EVALUATION; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HETEROZYGOSITY LOSS; HUMAN; IN VITRO STUDY; INFORMATION RETRIEVAL; PHENOTYPE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VIRUS MUTATION; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 33646047135     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00591.x     Document Type: Article

References (100)

1. WHO/47 Press Release Cervical cancer: experts confirmed virus a major cause, new detection technologies available July 3, 1996
2. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans; human papillomaviruses Lyon, France World Health Organization 1995
3. Hausen H Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1996 1288 55 78
4. Munger K Howley PM Human papillomavirus immortalization and transformation functions Virus Res 2002 89 213 28
5. Cox T Buck HW Kinney W Rubin MM Human papilloma virus and cervical cancer Clinical Proceedings March 2001
6. WHO Human papilloma virus (HPV). Summary of data reported and evaluation 1995
7. Bosch FX Manos MM Munoz N et al Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group J Natl Cancer Inst 1995 87 796 802
8. Ylitalo N Sorensen P Josefsson A et al Smoking and oral contraceptives as risk factors for cervical carcinoma in situ Int J Cancer 1999 81 357 65
9. Schiffman MH Brinton LA Devessa SS Fraumeni JF Jr. Cervical cancer In Schottenfeld D Fraumeni JF Jr. eds Cancer epidemiology and prevention New York, NY Oxford University Press 1996 1090 116
10. Magnusson PK Sparen P Gyllensten UB Genetic link to cervical tumours Nature 1999 400 29 30
11. Wolf JK Ramirez PT The molecular biology of cervical cancer Cancer Invest 2001 19 621 9
12. Tommasino M Accardi R Caldeira S et al The role of TP53 in cervical carcinogenesis Hum Mutat 2003 21 307 12
13. Lazo PA The molecular genetics of cervical carcinoma Br J Cancer 1999 80 2008 18
14. Baker SJ Fearon ER Nigro JM et al Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas Science 1989 244 217 21
15. Soussi T Dehouche K Beroud C p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis Hum Mutat 2000 15 105 13
16. Hollstein M Sidransky D Vogelstein B Harris CC p53 mutations in human cancers Science 1991 253 49 53
17. Lane DP Cancer. p53, guardian of the genome Nature 1992 358 15 6
18. Kern SE Kinzler KW Bruskin A et al Identification of p53 as a sequence-specific DNA-binding protein Science 1991 252 1708 11
19. Hsiao M Low J Dorn E et al Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness Am J Pathol 1994 145 702 14
20. Romanczuk H Villa LL Schlegel R Howley PM The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18 J Virol 1991 65 2739 44
21. Dyson N Howley PM Munger K Harlow E The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 1989 243 934 7
22. Scheffner M Werness BA Huibregtse JM Levine AJ Howley PM The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 1990 63 1129 36
23. Howley PM Role of the human papillomaviruses in human cancer Cancer Res 1991 51 18 Suppl 5019 22
24. Hernandez-Boussard T Rodriguez-Tome P Montesano R Hainaut P IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer Hum Mutat 1999 14 1 8
25. Hainaut P Hernandez T Robinson A et al IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools Nucleic Acids Res 1998 26 205 13
26. Hollstein M Hergenhahn M Yang Q Bartsch H Wang ZQ Hainaut P New approaches to understanding p53 gene tumor mutation spectra Mutat Res 1999 431 199 209
27. Hainaut P Hollstein M p53 and human cancer: the first ten thousand mutations Adv Cancer Res 2000 77 81 137
28. Beroud C Soussi T p53 gene mutation: software and database Nucleic Acids Res 1998 26 200 4
29. Dowell SP Wilson PO Deries NW Lane DP Hall PA Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens Cancer Res 1994 54 2914 8
30. Casey G Lopez ME Ramos JC et al DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies Oncogene 1996 13 1971 81
31. Borresen AL Helland A Nesland J Holm R Trope C Kaern J Papillomaviruses, p53, and cervical cancer Lancet 1992 339 1350 1
32. Fujita M Inoue M Tanizawa O Iwamoto S Enomoto T Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection Cancer Res 1992 52 5323 8
33. Crook T Wrede D Tidy JA Mason WP Evans DJ Vousden KH Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours Lancet 1992 339 1070 3
34. Paquette RL Lee YY Wilczynski SP et al Mutations of p53 and human papillomavirus infection in cervical carcinoma Cancer 1993 72 1272 80
35. Helland A Holm R Kristensen G et al Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas J Pathol 1993 171 105 14
36. Kessis TD Slebos RJ Han SM et al p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix Am J Pathol 1993 143 1398 405
37. Busby-Earle RM Steel CM Williams AR Cohen B Bird CC p53 mutations in cervical carcinogenesis - low frequency and lack of correlation with human papillomavirus status Br J Cancer 1994 69 732 7
38. Miwa K Miyamoto S Kato H et al The role of p53 inactivation in human cervical cell carcinoma development Br J Cancer 1995 71 219 26
39. Ikenberg H Matthay K Schmitt B et al p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas Cancer 1995 76 57 66
40. Kim KH Kim YS Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis Yonsei Med J 1995 36 412 25
41. Milde-Langosch K Albrecht K Joram S Schlechte H Giessing M Loning T Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva Int J Cancer 1995 63 639 45
42. Kim JW Cho YH Lee CG et al Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma Acta Oncol 1997 36 295 300
43. Ngan HY Tsao SW Liu SS Stanley M Abnormal expression and mutation of p53 in cervical cancer - a study at protein, RNA and DNA levels Genitourin Med 1997 73 54 8
44. Helland A Karlsen F Due EU Holm R Kristensen G Borresen-Dale A Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load Br J Cancer 1998 78 69 72
45. Tenti P Pavanello S Padovan L et al Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix Am J Pathol 1998 152 1057 63
46. Gostout BS Podratz KC McGovern RM Persing DH Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types, and p53 mutations Am J Obstet Gynecol 1998 179 56 61
47. Mullokandov MR Kholodilov NG Atkin NB Burk RD Johnson AB Klinger HP Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status Cancer Res 1996 56 197 205
48. Limpaiboon T Pooart J Bhattarakosol P Niruthisard S Chantratita W Lulitanond V p53 status and human papillomavirus infection in Thai women with cervical carcinoma Southeast Asian J Trop Med Public Health 2000 31 66 71
49. Pinheiro NA Villa LL Low frequency of p53 mutations in cervical carcinomas among Brazilian women Braz J Med Biol Res 2001 34 727 33
50. Harima Y Sawada S Nagata K Sougawa M Ohnishi T Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy Int J Cancer 2001 96 286 96
51. Denk C Butz K Schneider A Durst M Hoppe-Seyler F p53 mutations are rare events in recurrent cervical cancer J Mol Med 2001 79 283 8
52. Ishikawa H Mitsuhashi N Sakurai H Maebayashi K Niibe H The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone Cancer 2001 91 80 9
53. Gitsch G Kainz C Joura E Breitenecker G Mutant p53 product in patients with stage III cervical cancer Anticancer Res 1992 12 2241 2
54. Oka K Nakano T Arai T p53CM1 expression is not associated with prognosis in uterine cervical carcinoma Cancer 1993 72 160 4
55. Kainz C Kohlberger P Gitsch G Sliutz G Breitenecker G Reinthaller A Mutant p53 in patients with invasive cervical cancer stages IB to IIB Gynecol Oncol 1995 57 212 4
56. Benjamin I Saigo P Finstad C et al Expression and mutational analysis of P53 in stage IB and IIA cervical cancers Am J Obstet Gynecol 1996 175 1266 71
57. Kersemaekers AM Fleuren GJ Kenter GG et al Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis Clin Cancer Res 1999 5 577 86
58. Horn LC Fischer U Hanel C Kuhn H Raptis G Bilek K p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread Pathol Res Pract 2001 197 605 9
59. Ngan HY Cheung AN Liu SS Cheng DK Ng TY Wong LC Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis Oncol Rep 2001 8 557 61
60. Haensgen G Krause U Becker A et al Tumor hypoxia, p53, and prognosis in cervical cancers Int J Radiat Oncol Biol Phys 2001 50 865 72
61. Tsuda H Jiko K Tsugane S et al Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix Jpn J Cancer Res 1995 86 1049 53
62. Bremer GL Tieboschb AT van der Putten HW de Haan J Arends JW p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis Eur J Obstet Gynecol Reprod Biol 1995 63 55 9
63. Raju GC Teh M Wee A An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma Pathology 1996 28 17 9
64. Waggoner SE Anderson SM Luce MC Takahashi H Boyd J p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix Gynecol Oncol 1996 60 339 44
65. Uchiyama M Iwasaka T Matsuo N Hachisuga T Mori M Sugimori H Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix Gynecol Oncol 1997 65 23 9
66. Carrilho C Gouveia P Cantel M Alberto M Buane L David L Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women Pathol Res Pract 2003 199 303 11
67. Soussi T Beroud C Assessing TP53 status in human tumours to evaluate clinical outcome Nat Rev Cancer 2001 1 233 40
68. Marcial VA Marcial LY Radiation therapy of cervical cancer: new developments Cancer 1993 71 1438 45
69. Prives C Hall PA The p53 pathway J Pathol 1999 187 112 26
70. Bristow RG Benchimol S Hill RP The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy Radiother Oncol 1996 40 197 223
71. Niibe Y Nakano T Ohno T Tsujii H Oka K Relationship between p21/WAF-1/CIP-1 and apoptosis in cervical cancer during radiation therapy Int J Radiat Oncol Biol Phys 1999 44 297 303
72. Oka K Suzuki Y Nakano T Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis Cancer 2000 88 2766 73
73. Mukherjee G Freeman A Moore R et al Biologic factors and response to radiotherapy in carcinoma of the cervix Int J Gynecol Cancer 2001 11 187 93
74. Jain D Srinivasan R Patel FD Kumari Gupta S Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy Gynecol Oncol 2003 88 22 8
75. Rajkumar T Rajan S Baruah RK Majhi U Selvaluxmi G Vasanthan A Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix Eur J Gynaecol Oncol 1998 19 556 60
76. Ebara T Mitsuhashi N Saito Y et al Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone Gynecol Oncol 1996 63 216 8
77. Nakano T Oka K Ishikawa A Morita S Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer Cancer Detect Prev 1998 22 120 8
78. Hove MG Dinh TV Hannigan EV et al Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix J Reprod Med 1999 44 493 6
79. Atkin NB Cytogenetics of carcinoma of the cervix uteri: a review Cytogenet Cell Genet 1997 95 33 9
80. Atkin NB Baker MC Fox MF Chromosome changes in 43 carcinomas of the cervix uteri Cancer Genet Cytogenet 1990 44 229 41
81. Kinoshita M Shin S Hirao T Aono T A quantitative approach to the loss of heterozygosity in p53 allele on detection of human cervical cancer using a BioImaging Analyzer Asia Oceania J Obstet Gynaecol 1994 20 87 92
82. Mitra AB Murty VV Li RG Pratap M Luthra UK Chaganti RS Allelotype analysis of cervical carcinoma Cancer Res 1994 54 4481 7
83. Park SY Kang YS Kim BG et al Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas Cancer Genet Cytogenet 1995 79 74 8
84. Yamamoto Y Virmani AK Wistuba II. et al Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands Hum Pathol 1996 27 1204 10
85. Kim JW Lee CG Han SM et al Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection Gynecol Oncol 1997 67 215 21
86. Southern SA Herrington CS Interphase karyotypic analysis of chromosomes 11, 17 and X in invasive squamous carcinoma of the cervix: morphological correlation with HPV infection Int J Cancer 1997 70 502 7
87. Kersemaekers AMF Hermans J Fleuren GJ et al Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix Br J Cancer 1998 77 192 200
88. Helland A Kraggerud SM Kristensen GB et al Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival Int J Cancer 2000 88 217 22
89. Schork NJ Fallin D Lanchbury JS Single nucleotide polymorphisms and the future of genetic epidemiology Clin Genet 2000 58 250 64
90. Lee JE Lee SJ Namkoong SE et al Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer Int J Gynecol Cancer 2004 14 118 25
91. Harnadi Z Szarka K Sapy T Krasznai Z Veress G Poka R The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up BJOG 2003 110 205 9
92. Pillai MR Sreevidya S Pollock BH Jayaprakash PG Herman B Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India J Cancer Res Clin Oncol 2002 128 627 31
93. Nishikawa A Fujimoto T Akutagawa N et al p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer Int J Gynecol Cancer 2000 10 402 7
94. Klaes R Ridder R Schaefer U Benner A von Knebel Doeberitz M No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer J Mol Med 1999 77 299 302
95. Szarka K Veress G Juhasz A et al Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers Anticancer Res 2000 20 2161 7
96. Storey A Thomas M Kalita A Role of a 53 polymorphism in the development of human papillomavirus associated cancer Nature 1998 393 229 34
97. Rosenthal AN Ryan A Hopster D Jacobs IJ p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia Br J Cancer 2000 83 1287 90
98. Andersson S Rylander E Strand A Sallstrom J Wilander E The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas Br J Cancer 2001 85 1153 6
99. Koushik A Platt RW Franco EL p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review Cancer Epidemiol Biomarkers Prev 2004 13 11 22
100. Nagpal JK Sahni S Das BR p53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women Eur J Clin Invest 2002 32 943 8